Literature DB >> 22458541

Lactone metabolite common to the carcinogens dioxane, diethylene glycol, and N-nitrosomorpholine: aqueous chemistry and failure to mediate liver carcinogenesis in the F344 rat.

Niangoran Koissi1, Niti H Shah, Brandon Ginevan, William S Eck, Bill D Roebuck, James C Fishbein.   

Abstract

1,4-Dioxan-2-one, 1, was synthesized, and the equilibrium constant between it and the hydrolysis product 2-(2-hydroxyethoxy) acetic acid, 2, was determined as K(O) = 70 ± 4 in acidic aqueous media, 25 °C, ionic strength 1 M (KCl), and 5% by volume acetonitrile. The carboxylic acid dissociation constant of 2 was determined under the same conditions to be pK(a) = 3.31 ± 0.02. On the basis of these two determinations, the equilibrium constant between 1 and carboxylic acid anion, 3, and the proton was calculated to be K(OA) = 0.034 ± 0.002 M. The stability of 1 was determined in the range of pH between 1 and 8.5 in buffered aqueous solutions under the conditions above by UV spectrophotometric methods and exhibited simple first order kinetics of decay. On the basis of buffer dilution plots, the values of k(o), the rate constant for solvent mediated decomposition, were determined. The plot of log k(o) against pH is consistent with a three term rate law for solvolysis with a hydrogen ion catalyzed rate constant k(H+) = 1.1 (±0.1) M(-1) min(-1), a water catalyzed rate constant, k(w) = 9.9 (±0.5) × 10(-4) min(-1), and a hydroxide ion catalyzed rate constant, k(OH) = 4.1 (±0.3) × 10(4) M(-1) min(-1). The t(1/2) for decay at pH 7.0, at 25 °C, is ∼2 h. Treatment of F344 rats with aflatoxin B(1) (AFB(1)) (positive control) elicited the expected preneoplastic foci in the livers of each rat tested, while subsequent administration of 1 (a total of 1.32 g over 12 weeks) failed to statistically increase focal number or focal volume percent. In 8 rats administered 1 (1.32 g, 12 weeks) alone, no increase above background foci was detected. This study does not support compound 1 as a common carcinogen.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22458541      PMCID: PMC3358452          DOI: 10.1021/tx3000076

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  29 in total

1.  Metabolism in vivo of dioxane: identification of p-dioxane-2-one as the major urinary metabolite.

Authors:  Y T Woo; J C Arcos; M F Argus
Journal:  Biochem Pharmacol       Date:  1977-08-15       Impact factor: 5.858

2.  Products of the direct reaction of the diazonium ion of a metabolite of the carcinogen N-nitrosomorpholine with purines of nucleosides and DNA.

Authors:  Charles N Zink; Nicolas Soissons; James C Fishbein
Journal:  Chem Res Toxicol       Date:  2010-07-19       Impact factor: 3.739

3.  Studies on the carcinogenic activity of protein-denaturing agents: hepatocarcinogenicity of dioxane.

Authors:  M F Argus; J C Arcos; C Hochligeti
Journal:  J Natl Cancer Inst       Date:  1965-12       Impact factor: 13.506

4.  Hydrolysis of D-glucono-delta-lactone. I. General acid-base catalysis, solvent deuterium isotope effects, and transition state characterization.

Authors:  Y Pocker; E Green
Journal:  J Am Chem Soc       Date:  1973-01-10       Impact factor: 15.419

5.  Urinary bladder calculus and tumor response following either repeated feeding of diethylene glycol or calcium oxalate stone implantation.

Authors:  C S Weil; C P Carpenter; H F Smyth
Journal:  Ind Med Surg       Date:  1967-01

6.  Identification of beta-hydroxyethoxyacetic acid as the major urinary metabolite of 1,4-dioxane in the rat.

Authors:  W H Braun; J D Young
Journal:  Toxicol Appl Pharmacol       Date:  1977-01       Impact factor: 4.219

7.  Predictive value of molecular dosimetry: individual versus group effects of oltipraz on aflatoxin-albumin adducts and risk of liver cancer.

Authors:  T W Kensler; S J Gange; P A Egner; P M Dolan; A Muñoz; J D Groopman; A E Rogers; B D Roebuck
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1997-08       Impact factor: 4.254

8.  Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole.

Authors:  Melinda S Yates; Mi-Kyoung Kwak; Patricia A Egner; John D Groopman; Sridevi Bodreddigari; Thomas R Sutter; Karen J Baumgartner; B D Roebuck; Karen T Liby; Mark M Yore; Tadashi Honda; Gordon W Gribble; Michael B Sporn; Thomas W Kensler
Journal:  Cancer Res       Date:  2006-02-15       Impact factor: 12.701

9.  Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones.

Authors:  T W Kensler; P A Egner; P M Dolan; J D Groopman; B D Roebuck
Journal:  Cancer Res       Date:  1987-08-15       Impact factor: 12.701

10.  Evaluation of the post-initiation effects of oltipraz on aflatoxin B1-induced preneoplastic foci in a rat model of hepatic tumorigenesis.

Authors:  Y Y Maxuitenko; D L MacMillan; T W Kensler; B D Roebuck
Journal:  Carcinogenesis       Date:  1993-11       Impact factor: 4.944

View more
  1 in total

Review 1.  Metabolic Activation and DNA Interactions of Carcinogenic N-Nitrosamines to Which Humans Are Commonly Exposed.

Authors:  Yupeng Li; Stephen S Hecht
Journal:  Int J Mol Sci       Date:  2022-04-20       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.